Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update
20/11/2025 13:13
Chemomab Therapeutics Ltd CMMB.O: CHEMOMAB THERAPEUTICS ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE CHEMOMAB THERAPEUTICS LTD - CASH RUNWAY EXPECTED THROUGH END OF Q4 2026 Source text: ID:nGNX8Rxq65 Further company coverage: CMMB.O
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update